Harbin Pharma
Harbin Pharma, officially known as Harbin Pharmaceutical Group Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in Harbin, China. Established in 1994, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including traditional Chinese medicine, chemical drugs, and biopharmaceuticals. With a strong presence in both domestic and international markets, Harbin Pharma is recognised for its commitment to innovation and quality. The company’s core offerings, which include unique formulations and advanced therapeutic solutions, set it apart in a competitive landscape. Notably, Harbin Pharma has achieved several milestones, solidifying its position as a leader in the industry and contributing to advancements in healthcare.
DitchCarbon Score
How does Harbin Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Harbin Pharma's score of 10 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Harbin Pharma's reported carbon emissions
Harbin Pharma, headquartered in China (CN), currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As the industry evolves, it is expected that Harbin Pharma will align with these trends and establish measurable climate commitments in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Harbin Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
